|
1
|
McDonald ES, Clark AS, Tchou J, Zhang P
and Freedman GM: Clinical diagnosis and management of breast
cancer. J Nucl Med. 57 (Suppl 1):9S–16S. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta N, Gupta P and Srivastava SK:
Penfluridol overcomes paclitaxel resistance in metastatic breast
cancer. Sci Rep. 9:50662019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hassan MS, Ansari J, Spooner D and Hussain
SA: Chemotherapy for breast cancer (Review). Oncol Rep.
24:1121–1131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ghersi D, Willson ML, Chan MM, Simes J,
Donoghue E and Wilcken N: Taxane-containing regimens for metastatic
breast cancer. Cochrane Database Syst Rev.
10:CD0033662015.PubMed/NCBI
|
|
6
|
Megerdichian C, Olimpiadi Y and Hurvitz
SA: nab-Paclitaxel in combination with biologically targeted agents
for early and metastatic breast cancer. Cancer Treat Rev.
40:614–625. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bukowski K, Kciuk M and Kontek R:
Mechanisms of multidrug resistance in cancer chemotherapy. Int J
Mol Sci. 21:32332020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koual M, Tomkiewicz C, Cano-Sancho G,
Antignac JP, Bats AS and Coumoul X: Environmental chemicals, breast
cancer progression and drug resistance. Environ Health. 19:1172020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Li Z, Cui Y, Cui X, Chen C and
Wang Z: Exosomes isolated from bone marrow mesenchymal stem cells
exert a protective effect on osteoarthritis via lncRNA
LYRM4-AS1-GRPR-miR-6515-5p. Front Cell Dev Biol. 9:6443802021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L and Yu D: Exosomes in cancer
development, metastasis, and immunity. Biochim Biophys Acta Rev
Cancer. 1871:455–468. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Crow J, Atay S, Banskota S, Artale B,
Schmitt S and Godwin AK: Exosomes as mediators of platinum
resistance in ovarian cancer. Oncotarget. 8:11917–11936. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang F, Ning Z, Ma L, Liu W, Shao C, Shu Y
and Shen H: Exosomal miRNAs and miRNA dysregulation in
cancer-associated fibroblasts. Mol Cancer. 16:1482017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Li S, Li L, Li M, Guo C, Yao J
and Mi S: Exosome and exosomal microRNA: Trafficking, sorting, and
function. Genomics Proteomics Bioinformatics. 13:17–24. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geretto M, Pulliero A, Rosano C, Zhabayeva
D, Bersimbaev R and Izzotti A: Resistance to cancer
chemotherapeutic drugs is determined by pivotal microRNA
regulators. Am J Cancer Res. 7:1350–1371. 2017.PubMed/NCBI
|
|
16
|
Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T,
Wen H, Yang Y, Wang S, Wang J, et al: Exosomal microRNA-32-5p
induces multidrug resistance in hepatocellular carcinoma via the
PI3K/Akt pathway. J Exp Clin Cancer Res. 37:522018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fornari F, Pollutri D, Patrizi C, Bella
TL, Marinelli S, Gardini AS, Marisi G, Toaldo MB, Baglioni M,
Salvatore V, et al: In hepatocellular carcinoma miR-221 modulates
sorafenib resistance through inhibition of caspase-3-mediated
apoptosis. Clin Cancer Res. 23:3953–3965. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uhr K, Prager-van der Smissen WJC, Heine
AAJ, Ozturk B, van Jaarsveld MTM, Boersma AWM, Jager A, Wiemer EAC,
Smid M, Foekens JA and Martens JWM: MicroRNAs as possible
indicators of drug sensitivity in breast cancer cell lines. PLoS
One. 14:e02164002019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thery C, Amigorena S, Raposo G and Clayton
A: Isolation and characterization of exosomes from cell culture
supernatants and biological fluids. Curr Protoc Cell Biol Chapter
3. Unit 3.22. 2006.PubMed/NCBI
|
|
20
|
Lee YS, Kim SY, Ko E, Lee JH, Yi HS, Yoo
YJ, Je J, Suh SJ, Jung YK, Kim JH, et al: Exosomes derived from
palmitic acid-treated hepatocytes induce fibrotic activation of
hepatic stellate cells. Sci Rep. 7:37102017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martins TS, Catita J, Rosa IK, Silva OA
and Henriques AG: Exosome isolation from distinct biofluids using
precipitation and column-based approaches. PLoS One.
13:e01988202018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu M, Ouyang Y, Wang Z, Zhang R, Huang PH,
Chen C, Li H, Li P, Quinn D, Dao M, et al: Isolation of exosomes
from whole blood by integrating acoustics and microfluidics. Proc
Natl Acad Sci USA. 114:10584–10589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liao Z, Chen Y, Duan C, Zhu K, Huang R,
Zhao H, Hintze M, Pu Q, Yuan Z, Lv L, et al: Cardiac telocytes
inhibit cardiac microvascular endothelial cell apoptosis through
exosomal miRNA-21-5p-targeted cdip1 silencing to improve
angiogenesis following myocardial infarction. Theranostics.
11:268–291. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang C, Liu X, Zhao K, Zhu Y, Hu B, Zhou
Y, Wang M, Wu Y, Zhang C, Xu J, et al: miRNA-21 promotes
osteogenesis via the PTEN/PI3K/Akt/HIF-1alpha pathway and enhances
bone regeneration in critical size defects. Stem Cell Res Ther.
10:652019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park ST and Kim J: Trends in
next-generation sequencing and a new era for whole genome
sequencing. Int Neurourol J. 20:S76–S83. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kolak A, Kaminska M, Sygit K, Budny A,
Surdyka D, Kukiełka-Budny B and Burdan F: Primary and secondary
prevention of breast cancer. Ann Agric Environ Med. 24:549–553.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Denkert C, Liedtke C, Tutt A and von
Minckwitz G: Molecular alterations in triple-negative breast
cancer-the road to new treatment strategies. Lancet. 389:2430–2442.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang S, Zhang H, Ghia EM, Huang J, Wu L,
Zhang J, Lam S, Lei Y, He J, Cui B, et al: Inhibition of
chemotherapy resistant breast cancer stem cells by a ROR1 specific
antibody. Proc Natl Acad Sci U S A. 116:1370–1377. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mashouri L, Yousefi H, Aref AR, Ahadi AM,
Molaei F and Alahari SK: Exosomes: composition, biogenesis, and
mechanisms in cancer metastasis and drug resistance. Mol Cancer.
18:752019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Santos JC, Lima NDS, Sarian LO, Matheu A,
Ribeiro ML and Derchain SFM: Exosome-mediated breast cancer
chemoresistance via miR-155 transfer. Sci Rep. 8:8292018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kampan NC, Madondo MT, McNally OM, Quinn M
and Plebanski M: Paclitaxel and its evolving role in the management
of ovarian cancer. Biomed Res Int. 2015:4130762015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weaver BA: How Taxol/paclitaxel kills
cancer cells. Mol Biol Cell. 25:2677–2681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li Z, Lin C, Zhao L, Zhou L, Pan X, Quan
J, Peng X, Li W, Li H, Xu J, et al: Oncogene miR-187-5p is
associated with cellular proliferation, migration, invasion,
apoptosis and an increased risk of recurrence in bladder cancer.
Biomed Pharmacother. 105:461–469. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu YB, Yan C, Mu L, Mi YL, Zhao H, Hu H,
Li XL, Tao DD, Wu YQ, Gong JP and Qin JC: Exosomal Wnt-induced
dedifferentiation of colorectal cancer cells contributes to
chemotherapy resistance. Oncogene. 38:1951–1965. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X,
Shen B, Liu S, Yan D and Feng J: Cisplatin-resistant lung cancer
cell-derived exosomes increase cisplatin resistance of recipient
cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine.
12:3721–3733. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dey N, Barwick BG, Moreno CS,
Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C,
Kerstann KF, Sledge GW Jr, et al: Wnt signaling in triple negative
breast cancer is associated with metastasis. BMC Cancer.
13:5372013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hlavac V, Brynychova V, Vaclavikova R,
Ehrlichová M, Vrána D, Pecha V, Koževnikovová R, Trnková M, Gatěk
J, Kopperová D, et al: The expression profile of ATP-binding
cassette transporter genes in breast carcinoma. Pharmacogenomics.
14:515–529. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Soucek P, Hlavac V, Elsnerova K,
Vaclavikova R, Kozevnikovova R and Raus K: Whole exome sequencing
analysis of ABCC8 and ABCD2 genes associating with clinical course
of breast carcinoma. Physiol Res. 64:S549–S557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Park CY, Kim HS, Jang J, Lee H, Lee JS,
Yoo JE, Lee DR and Kim DW: ABCD2 is a direct target of beta-catenin
and TCF-4: Implications for X-linked adrenoleukodystrophy therapy.
PLoS One. 8:e562422013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jia XX, Zhu TT, Huang Y, Zeng XX, Zhang H
and Zhang WX: Wnt/β-catenin signaling pathway regulates asthma
airway remodeling by influencing the expression of c-Myc and cyclin
D1 via the p38 MAPK-dependent pathway. Exp Ther Med. 18:3431–3438.
2019.PubMed/NCBI
|
|
43
|
Lin SY, Xia W, Wang JC, Kwong KY, Spohn B,
Wen Y, Pestell RG and Hung MC: Beta-catenin, a novel prognostic
marker for breast cancer: Its roles in cyclin D1 expression and
cancer progression. Proc Natl Acad Sci USA. 97:4262–4266. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shi Q, Li Y, Li S, Jin L, Lai H, Wu Y, Cai
Z, Zhu M, Li Q, Li Y, et al: LncRNA DILA1 inhibits Cyclin D1
degradation and contributes to tamoxifen resistance in breast
cancer. Nat Commun. 11:55132020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gosens R, Baarsma HA, Heijink IH, Oenema
TA, Halayko AJ, Meurs H and Schmidt M: De novo synthesis of
{beta}-catenin via H-Ras and MEK regulates airway smooth muscle
growth. FASEB J. 24:757–768. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu J, Zhang P, Sun H and Liu Y:
LINC01094/miR-577 axis regulates the progression of ovarian cancer.
J Ovarian Res. 13:1222020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cheng R, Liu YJ, Cui JW, Yang M, Liu XL,
Li P, Wang Z, Zhu LZ, Lu SY, Zou L, et al: Aspirin regulation of
c-myc and cyclinD1 proteins to overcome tamoxifen resistance in
estrogen receptor-positive breast cancer cells. Oncotarget.
8:30252–30264. 2017. View Article : Google Scholar : PubMed/NCBI
|
